Original article

Ahead-of-Print

In vitro regenerative effects of a pooled pathogen-reduced lyophilized human cord blood platelet lysate for wound healing applications

Authors

Key words: umbilical cord blood, platelet concentrates, heparin, regenerative medicine, pooling

Abstract

Background - Cord blood platelets, easily obtained from blood units not suitable for haematopoietic stem cell transplantation, represent an abundant source of growth factors for use in wound healing. Although several protocols have been described for platelet lysate production, no standard manufacturing protocol is available. The use of pooled cord blood platelets could thus facilitate standardization. In this study, the effect of varying concentrations (up to 20%) of a pooled pathogen-reduced lyophilized cord blood platelet lysate (PRL-CBPL) was investigated in different cell types involved in the wound healing process. The effect of heparin addition was also evaluated. In parallel, a comparison was performed with a single donor cord blood platelet lysate (SD-CBPL).

Materials and methods - The effect of PRL-CBPL on the viability and proliferation of different cell lines (L929 mouse fibroblasts and HaCaT keratinocytes) and human primary cells (fibroblasts-NHDF, coronary artery smooth muscle cells-HCASMC and coronary artery endothelial cells-HCAEC), on HaCaT migration and the chemotactic effect on human monocytes (THP-1) was evaluated.

Results - PRL-CBPL showed a lower PDGF-AB amount compared to SD-CBPL. Differing concentrations of both CBPL were necessary to influence cell viability and proliferation. 3% was the optimal concentration for L929 and HaCaT as well as for NHDF and HCASMC, while HCAEC required 10%. The effect of added heparin was more evident on SD-CBPL and in particular on NHDF and HCASMC proliferation. Keratinocyte scratch closure was obtained with 3 and 5% PRL-CBPL and SD-CBPL respectively. Both CBPLs caused an increase in the number of migrated THP-1 monocytes in a concentration-dependent manner up to 20% with a higher monocyte migration for SD-CBPL with respect to PRL-CBPL and in cells treated with heparin.

Discussion - The data obtained suggest that PRL-CBPL is an effective standardized alternative to SD-CBPL.

Downloads

Authors

Marianna Buscemi - Institute of Clinical Physiology, CNR, Massa, Italy

Aida Cavallo - Institute of Clinical Physiology, CNR, Massa, Italy

Marco Fabbri - Transfusion Medicine and Transplant Biology, Pisa University Hospital, Pisa, Italy

Sabrina Gabbriellini - Transfusion Medicine and Transplant Biology, Pisa University Hospital, Pisa, Italy

Elena Ciabatti - Transfusion Medicine and Transplant Biology, Pisa University Hospital, Pisa, Italy

Alessandro Mazzoni - Transfusion Medicine and Transplant Biology, Pisa University Hospital, Pisa, Italy

Giorgio Soldani - Institute of Clinical Physiology, CNR, Massa, Italy

Paolo Rebulla - Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Paola Losi - Institute of Clinical Physiology, CNR, Massa, Italy

  • Abstract viewed - 32 times
  • pdf downloaded - 22 times